AccurKardia
Evolutionary technology is setting the standard for AI-powered heart rhythm analytics and diagnostics.
Launch date
Employees
Market cap
-
Enterprise valuation
€10—15m (Dealroom.co estimates Jun 2023.)
New York City New York (HQ)
Financials
Estimates*
USD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | <1m | <1m | <1m |
% growth | - | 14 % | 25 % |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Seed | ||
N/A | N/A | Seed | |
N/A | $450k | Seed | |
N/A | $1.4m | Seed | |
* | $2.7m | Seed | |
* | N/A | - | |
Total Funding | €4.1m |
Related Content
Recent News about AccurKardia
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.